| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216777 Immobilization on solid support |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216310 administering to mammal more than one dose of a composition comprising live Newcastle Disease Virus in an amount sufficient to cause tumor regression |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | DE19917195B4 Peptid zur Auslösung einer Immunreaktion gegen Tumorzellen, diese enthaltende pharmzeutische Zusammensetzungen, dessen Verwendungen, dafür codierende Nukleinsäure und diese Nukleinsäure enthaltender Expressionsvektor Peptide to induce an immune response against tumor cells containing this pharmzeutische compositions, uses thereof, nucleic acid coding therefor and these nucleic acid expression vector containing |
| 09/28/2006 | CA2602956A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | CA2602893A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | CA2602559A1 Agent for treatment of hematopoietic tumor |
| 09/28/2006 | CA2602541A1 Isoflavonoid dimers |
| 09/28/2006 | CA2602397A1 Therapeutic agent for solid tumor |
| 09/28/2006 | CA2602375A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | CA2602374A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | CA2602328A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | CA2602324A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/28/2006 | CA2602316A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 09/28/2006 | CA2602099A1 Methods for treating or preventing acute myelogenous leukemia |
| 09/28/2006 | CA2601858A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | CA2601766A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | CA2601640A1 Use of macrolides for treating intestinal inflammation |
| 09/27/2006 | EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 09/27/2006 | EP1705248A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1705182A1 Antitumoral and antiviral peptides |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1705177A1 N-aryl-sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents |
| 09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
| 09/27/2006 | EP1704870A1 Use of iron compounds as radiosensitizers |
| 09/27/2006 | EP1704868A1 HLA binding peptides and their uses |
| 09/27/2006 | EP1704864A2 Process for producing an injectable pharmaceutical preparation |
| 09/27/2006 | EP1704863A2 Combination comprising N-5-4-(4-Methyl-Piperazino-Methyl-)Benzoyla Mido]-2-Methylphenyl -4-(3-Pyridyl)-2Phyrimidine-amine and a chemotherapeutic agent |
| 09/27/2006 | EP1704855A2 2-Cyclopenten-1-one and its Derivatives as Inhibitors of the NF-kappa B Factor |
| 09/27/2006 | EP1704161A1 Helix 12 directed steroidal pharmaceutical products |
| 09/27/2006 | EP1704156A1 Platinum(ii) complexes, preparation and use |
| 09/27/2006 | EP1704151A1 Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12] urils |
| 09/27/2006 | EP1704150A1 2,3-dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 09/27/2006 | EP1704148A1 Novel fused pyrrolocarbazoles |
| 09/27/2006 | EP1704147A1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM |
| 09/27/2006 | EP1704136A1 Gossypol derivatives, production method thereof and uses of same |
| 09/27/2006 | EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 09/27/2006 | EP1703904A2 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 09/27/2006 | EP1703893A2 Novel anti-il 13 antibodies and uses thereof |
| 09/27/2006 | EP1615638B1 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1337521B1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 09/27/2006 | EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | EP1180016B1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | EP1140196B1 pharmaceutical solutions comprising triphenylethylene antiestrogens |
| 09/27/2006 | EP0951286B1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 09/27/2006 | EP0759786B1 Somatostatin binding peptide-metal chelate conjugates |
| 09/27/2006 | CN1839202A Process for producing cytotoxic lymphocytes |
| 09/27/2006 | CN1839148A Cytotoxic depsipeptides |
| 09/27/2006 | CN1839139A Proteasome inhibitors and methods of using the same |
| 09/27/2006 | CN1839133A Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 09/27/2006 | CN1839132A N3-substituted imidazopyridine-derivatives as C-KIT inhibitors |
| 09/27/2006 | CN1839130A N-substituted pyrazolyl-amidyl-benzimidazolyl C-KIT inhibitors |
| 09/27/2006 | CN1839129A Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
| 09/27/2006 | CN1839128A Mitotic kinesin inhibitors |
| 09/27/2006 | CN1839126A Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/27/2006 | CN1838965A Drug for cancer therapy |
| 09/27/2006 | CN1838959A Dosing schedule for ERBB2 anticancer agent |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1837241A Interactive molecular binding domain of angiogenin and LIM protein |
| 09/27/2006 | CN1837240A Interactive molecular binding domain of angiogenin and lambda crystallin |
| 09/27/2006 | CN1837223A Novel process for synthesis of oxaliplatin as anticancer medicine |
| 09/27/2006 | CN1837210A Specific penicillium ketone compounds, process for preparing same and use thereof |
| 09/27/2006 | CN1837206A Sesquiterpene subergorgia suberosa ketone and its preparing process and application |
| 09/27/2006 | CN1836732A Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour |
| 09/27/2006 | CN1836729A Target antibody compound for killing tumour cell and its preparation method |
| 09/27/2006 | CN1836722A Traditional Chinese medicine for treating gynaecologic disease |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836708A Aliphatic acid synthase inhibitor and method for making same and uses |
| 09/27/2006 | CN1836707A Medicine for treating tumour and its preparing method |
| 09/27/2006 | CN1836706A Chinese traditional medicine composition for treating leucopenia and preparation and quality controlling method thereof |
| 09/27/2006 | CN1836702A Medicine for treating tumour and its preparing method |
| 09/27/2006 | CN1836684A Silktree albizzia general saponin and its extraction method, pharmaceutical use of the said composition and medicine preparation |
| 09/27/2006 | CN1836683A Medicine for treating tumour and its preparing method |
| 09/27/2006 | CN1836676A Method for preparing and controlling the quality of lucid ganoderma spore powder soft capsule |
| 09/27/2006 | CN1836675A Tablet containing lucid ganoderma and spirulina spp. ,and its preparation method |
| 09/27/2006 | CN1836674A Antler lucid ganoderma and its extract for preparing pharmaceutical and food for treating cancer and immunity effect |
| 09/27/2006 | CN1836657A Polymethoxylated flavones and its preparation method |
| 09/27/2006 | CN1836650A Antineoplastic precharging preparation |
| 09/27/2006 | CN1276923C Crystalline polymorphic form of irinotecan hydrochloride |
| 09/27/2006 | CN1276754C Treatment of gastrointestinal stromal tumors |
| 09/27/2006 | CN1276751C Application of scutellaria root extract in preparation of anti-stomach cancer medicine |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112698 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112676 Pyrimido compounds having antiproliferative activity |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |